TRIAZOLOPYRIDINE COMPOUNDS AS PIM KINASE INHIBITORS

Compounds of Formula (I), in which A, B, R1, R1a, R2, R3, R4, R5, R6, and R7 have the meanings given in the specification, are receptor tyrosine inhibitors useful in the treatment of immune cell-associated diseases and disorders, such as inflammatory and autoimmune diseases.

Saved in:
Bibliographic Details
Main Authors LYSSIKATOS, JOSEPH P, MUNSON, MARK C, RAST, BRYSON, DELISLE, ROBERT KIRK, GROSS, STEFAN D, DAVIS, T. GREGG, TOPALOV, GEORGE T, HICKEN, ERIK JAMES, WRIGHT, A. DALE, CELESTE, LAURA L, ROBINSON, JOHN E, ZHAO, QIAN, KALLAN, NICHOLAS C, PHENEGER, JED, GRESCHUK, JULIE MARIE, ALLEN, SHELLEY, MARMSATER, FREDRIK P, JACKSON, LEILA J, SCHLACHTER, STEPHEN T
Format Patent
LanguageCroatian
English
Published 03.01.2014
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:Compounds of Formula (I), in which A, B, R1, R1a, R2, R3, R4, R5, R6, and R7 have the meanings given in the specification, are receptor tyrosine inhibitors useful in the treatment of immune cell-associated diseases and disorders, such as inflammatory and autoimmune diseases.
Bibliography:Application Number: HR2013P001140T